Anat Biegon

11.7k total citations
187 papers, 8.4k citations indexed

About

Anat Biegon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Anat Biegon has authored 187 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Cellular and Molecular Neuroscience, 48 papers in Molecular Biology and 26 papers in Pharmacology. Recurrent topics in Anat Biegon's work include Neuroscience and Neuropharmacology Research (71 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Receptor Mechanisms and Signaling (26 papers). Anat Biegon is often cited by papers focused on Neuroscience and Neuropharmacology Research (71 papers), Neurotransmitter Receptor Influence on Behavior (34 papers) and Receptor Mechanisms and Signaling (26 papers). Anat Biegon collaborates with scholars based in United States, Israel and Spain. Anat Biegon's co-authors include Bruce S. McEwen, Thomas C. Rainbow, Malka Israeli, Ruth Gross‐Isseroff, David Samuel, BS McEwen, Esther Shohami, Joanna S. Fowler, Menahem Segal and Kathryn Dillon and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Neuroscience.

In The Last Decade

Anat Biegon

183 papers receiving 8.1k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Anat Biegon 3.5k 2.2k 1.1k 1.1k 945 187 8.4k
Robert H. Lipsky 2.5k 0.7× 2.6k 1.2× 709 0.6× 970 0.9× 557 0.6× 112 8.1k
Mark D. Underwood 3.0k 0.8× 1.6k 0.7× 679 0.6× 1.1k 1.0× 1.1k 1.2× 98 6.6k
Andrew J. Dwork 3.0k 0.8× 3.5k 1.6× 799 0.7× 1.7k 1.5× 1.1k 1.2× 140 10.4k
Rosalinda C. Roberts 3.5k 1.0× 2.7k 1.2× 496 0.4× 1.1k 1.0× 1.3k 1.3× 139 7.6k
Markku Linnoila 3.9k 1.1× 1.6k 0.7× 1.1k 1.0× 1.7k 1.6× 1.1k 1.1× 280 10.6k
Alan Frazer 4.8k 1.4× 3.0k 1.3× 1.7k 1.5× 1.3k 1.2× 1.4k 1.5× 211 10.3k
Hans‐Gert Bernstein 2.9k 0.8× 3.1k 1.4× 684 0.6× 1.3k 1.1× 1.5k 1.6× 254 10.3k
Chawki Benkelfat 4.0k 1.1× 1.6k 0.7× 954 0.8× 2.4k 2.2× 722 0.8× 178 8.9k
Nicholas M. Barnes 4.0k 1.1× 3.3k 1.5× 761 0.7× 823 0.7× 545 0.6× 147 7.7k
Gregers Wegener 2.6k 0.7× 1.9k 0.9× 1.6k 1.4× 835 0.8× 1.9k 2.0× 252 8.1k

Countries citing papers authored by Anat Biegon

Since Specialization
Citations

This map shows the geographic impact of Anat Biegon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Biegon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Biegon more than expected).

Fields of papers citing papers by Anat Biegon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anat Biegon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Biegon. The network helps show where Anat Biegon may publish in the future.

Co-authorship network of co-authors of Anat Biegon

This figure shows the co-authorship network connecting the top 25 collaborators of Anat Biegon. A scholar is included among the top collaborators of Anat Biegon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anat Biegon. Anat Biegon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petersen, Eric, Dinko Franceschi, Mony J. de Leon, et al.. (2023). A conformal TOF–DOI Prism‐PET prototype scanner for high‐resolution quantitative neuroimaging. Medical Physics. 50(6). 3401–3417. 42 indexed citations
2.
Biegon, Anat, Nelly Alia‐Klein, David Alexoff, et al.. (2020). Relationship of estrogen synthesis capacity in the brain with obesity and self-control in men and women. Proceedings of the National Academy of Sciences. 117(37). 22962–22966. 13 indexed citations
3.
Biegon, Anat. (2015). In vivo visualization of aromatase in animals and humans. Frontiers in Neuroendocrinology. 40. 42–51. 29 indexed citations
4.
Biegon, Anat, David Alexoff, Sung Won Kim, et al.. (2015). Aromatase Imaging with [N-Methyl-11C]Vorozole PET in Healthy Men and Women. Journal of Nuclear Medicine. 56(4). 580–585. 44 indexed citations
5.
Biegon, Anat, et al.. (2007). Metabolic and behavioral deficits following a routine surgical procedure in rats. Brain Research. 1144. 209–218. 24 indexed citations
6.
7.
Biegon, Anat. (2004). Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury. Current Pharmaceutical Design. 10(18). 2177–2183. 29 indexed citations
8.
Knoller, Nachshon, Leon Levi, Eli Reichenthal, et al.. (2002). Dexanabinol (HU-211) in the treatment of severe closed head injury: A randomized, placebo-controlled, phase II clinical trial*. Critical Care Medicine. 30(3). 548–554. 117 indexed citations
9.
Biegon, Anat, Maritza Alvarado, Thomas F. Budinger, et al.. (2002). Region‐selective effects of neuroinflammation and antioxidant treatment on peripheral benzodiazepine receptors and NMDA receptors in the rat brain. Journal of Neurochemistry. 82(4). 924–934. 38 indexed citations
10.
Biegon, Anat & Ilan A. Kerman. (2001). Autoradiographic Study of Pre- and Postnatal Distribution of Cannabinoid Receptors in Human Brain. NeuroImage. 14(6). 1463–1468. 101 indexed citations
11.
Achiron, Anat, Shmuel Miron, Vered Lavie, Raanan Margalit, & Anat Biegon. (2000). Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. Journal of Neuroimmunology. 102(1). 26–31. 65 indexed citations
12.
Gallily, Ruth, Aviva Yamin, Haim Ovadia, et al.. (1997). Protection Against Septic Shock and Suppression of Tumor Necrosis Factor α and Nitric Oxide Production by Dexanabinol (HU-211), a Nonpsychotropic Cannabinoid. Journal of Pharmacology and Experimental Therapeutics. 283(2). 918–924. 29 indexed citations
13.
Striem, S., et al.. (1997). Interaction of Dexanabinol (HU-211), a novel NMDA receptor antagonist, with the dopaminergic system. European Journal of Pharmacology. 338(3). 205–213. 11 indexed citations
14.
Biegon, Anat. (1995). Neuroprotective Activity of HU‐211, a Novel Nonpsychotropic Synthetic Cannabinoid. Annals of the New York Academy of Sciences. 765(1). 314–314. 9 indexed citations
15.
Biegon, Anat, Chester A. Mathis, & Thomas F. Budinger. (1992). Quantitative in vitro and ex vivo autoradiography of the α2-adrenoceptor antagonist [3H]atopamezole. European Journal of Pharmacology. 224(1). 27–38. 30 indexed citations
16.
Gross‐Isseroff, Ruth, Kathryn Dillon, Malka Israeli, & Anat Biegon. (1990). Regionally selective increases in μ opioid receptor density in the brains of suicide victims. Brain Research. 530(2). 312–316. 133 indexed citations
17.
Gross‐Isseroff, Ruth, et al.. (1990). Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide. Brain Research. 507(2). 208–215. 83 indexed citations
18.
Biegon, Anat. (1990). Effects of Steroid Hormones on the Serotonergic System. Annals of the New York Academy of Sciences. 600(1). 427–432. 47 indexed citations
19.
Biegon, Anat, et al.. (1987). Serotonin 5-HT2 receptor binding on blood platelets - a peripheral marker for depression?. Life Sciences. 41(22). 2485–2492. 148 indexed citations
20.
Biegon, Anat & David Samuel. (1979). The in vivo distribution of an antidepressant drug (DMI) in male and female rats. Psychopharmacology. 65(3). 259–263. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert H. Lipsky Breakdown of academic impact, for papers by Mark D. Underwood Breakdown of academic impact, for papers by Andrew J. Dwork Breakdown of academic impact, for papers by Rosalinda C. Roberts Breakdown of academic impact, for papers by Markku Linnoila Breakdown of academic impact, for papers by Alan Frazer Breakdown of academic impact, for papers by Hans‐Gert Bernstein Breakdown of academic impact, for papers by Chawki Benkelfat Breakdown of academic impact, for papers by Nicholas M. Barnes Breakdown of academic impact, for papers by Gregers Wegener
Rankless by CCL
2026